GlassScriptPhysician profile
Amandeep Kaur
NPI 1417297250
$6,012.88
in general payments reported to CMS, 2019-2025
44 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what 78% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $401 · 2021: $588 · 2022: $577 · 2023: $747 · 2024: $1,298 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,937.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,371.76 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $856.09 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Novartis Pharmaceuticals Corporation | $362.26 | 2023-2025 | |
| Ucb, INC. | $216.16 | 2022-2025 | Briviact, Fintepla, Rystiggo |
| Regeneron Healthcare Solutions, INC. | $207.33 | 2023-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $188.62 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $184.79 | 2025 | Omvoh, Kisunla, Amyvid |
| Intercept Pharmaceuticals, INC. | $183.81 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $174.77 | 2021-2025 | Entyvio, Gattex |
| Pfizer INC. | $172.07 | 2022-2025 | |
| Gilead Sciences, INC. | $167.55 | 2020-2023 | |
| Romark Laboratories, Lc | $164.87 | 2020 | |
| Axonics, INC. | $162.66 | 2024 | Axonics |
| Braintree Laboratories, INC. | $145.51 | 2020-2021 | |
| Celltrion USA INC. | $132.55 | 2025 | Vegzelma |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amandeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.